InMode reported Q2 2026 revenue of $95.6 million, beating FactSet consensus of $93.1 million and demonstrating sustained demand for its radiofrequency and ultrasonic microneedling platforms in the U.S. market. The beat came despite a competitive device landscape and ongoing capital-equipment purchasing cycles that typically lag consumer demand.